Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union

  1. Wyrwicz, L.
  2. Rodríguez Sánchez, C.A.
  3. Sánchez-Rovira, P.
  4. Lewis, S.
  5. Sandschafer, D.
  6. San, T.
Aldizkaria:
Future oncology (London, England)

ISSN: 1744-8301

Argitalpen urtea: 2024

Alea: 20

Zenbakia: 13

Orrialdeak: 821-832

Mota: Artikulua

DOI: 10.2217/FON-2023-0421 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus